Home
Conditions
Hepatitis

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,969 public trials 189 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects

NCT03662568

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Completed

Safety and Efficacy Study to Compare Continuous Infusion of Interferon With Standard of Care for Chronic Hepatitis C

NCT00919633

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: Duke Clinical Research Institute Durham, North Carolina, United States

View Trial Details

Completed

Brief Intervention for Rural Women at High Risk for HIV/HCV

NCT01840722

Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +24 more
Locations: Rural Appalachian Research Center Hazard, Kentucky, United States

View Trial Details

Completed

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)

NCT02615145

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations: Not specified

View Trial Details

Completed

Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B

NCT00869778

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: The PLA Beijing Military General Hospital Beijing, Beijing Municipality, China

The 2nd Affiliated Hosptial of Harbin Medical University Harbin, Heilongjiang, China

Renmin Hosptial of Wuhan University Wuhan, Hubei, China

The Second Xiangya Hospital of Central South University Changsha, Hunan, China

View all 15 locations

View Trial Details

Completed

Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers

NCT01106092

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +22 more
Locations: GSK Investigational Site City of Muntinlupa, Philippines

View Trial Details

Completed

Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study

NCT01502397

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations: Department of Medicine, The University of Hong Kong, Queen Mary Hospital Hong Kong

View Trial Details

Completed

Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir

NCT03063879

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Renal Failure, +24 more
Locations: Shariati Hospital Tehran, Iran

View Trial Details

Completed

Entecavir for Decompensated HBV Cirrhosis

NCT03345498

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
Locations: Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow, Uttar Pradesh, India

View Trial Details

Completed

A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia

NCT02858440

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +25 more
Locations: GSK Investigational Site Barnaul, Russia

GSK Investigational Site Murmansk, Russia

GSK Investigational Site Saint Petersburg, Russia

GSK Investigational Site Tomsk, Russia

View Trial Details

Hepatitis

Hepatitis trial results

Related conditions